Related by context. All words. (Click for frequent words.) 69 Meta Analysis 67 Study Evaluating 67 Controlled Trial 65 Patients Undergoing 65 Randomized Controlled Trial 65 Controlled Study 65 Adjuvant Chemotherapy 64 Relapsing Multiple Sclerosis 64 Clinical Outcome 64 Randomized Study 64 Prospective Randomized Trial 64 Intervention Trial 64 Venous Thromboembolism 64 Randomized Evaluation 64 Clinical Trial Evaluating 64 Cardiovascular Outcomes 63 Systematic Review 63 Hypertensive Patients 63 Long Term Efficacy 63 Multicenter Study 63 Adjuvant Therapy 63 Aggressive Reduction 62 Neoadjuvant Chemotherapy 62 Improves Outcomes 62 Carotid Stenting 62 Targeted Therapy 62 Progenitor Cells 62 Improves Survival 62 Randomized Clinical Trial 62 Study Demonstrates 62 Cardiovascular Events 62 Oral Fingolimod 62 Infarct 62 Inhibits 62 Subgroup Analysis 62 Pharmacokinetic Study 62 Hemodialysis Patients 62 Heart Failure Patients 62 Myocardial Ischemia 62 Left Ventricular 62 Appears Safe 62 Autologous Stem Cell Transplantation 62 Prolongs Survival 61 Radical Prostatectomy 61 Bone Metastases 61 Prospective Randomized 61 HER2 Positive 61 Carotid Endarterectomy 61 Shows Promising 61 Patients Receiving 61 Metastatic Prostate Cancer 61 Anti Tumor Activity 61 Localized Prostate Cancer 61 Proves Effective 61 Trial Evaluating 61 Cholesterol Levels SPARCL 61 Randomised 61 Placebo Controlled Trial 61 Patients Treated 61 Pooled Analysis 61 Preclinical Study 61 Node Positive 61 Placebo Controlled 61 Prospective Multicenter 61 Systolic Blood Pressure 61 Mouse Model 61 Total Knee Arthroplasty 61 Hormone Receptor Positive 61 Phase 2b Study 60 Knee Osteoarthritis 60 Cerebrospinal Fluid 60 Chronic Hepatitis C 60 Reduces Mortality 60 Allogeneic 60 Clinical Evaluation 60 Shown Effective 60 Adjuvant Treatment 60 Randomized Controlled 60 Randomized Double Blind 60 Autologous 60 Left Ventricular Dysfunction 60 Randomized Trials 60 Pulmonary Arterial Hypertension 60 Thromboembolism 60 Sipuleucel T 60 Venous Thrombosis 60 Newly Diagnosed Multiple Myeloma 60 Phase III Trial 60 Elderly Patients 60 Platelet Inhibition 60 Increases Risk 60 Breast Cancer Cells 60 Shows Promise Against 60 Double Blind Randomized 60 Clinical Trial Results 60 Drug Shows Promise 60 Abciximab 59 Randomized Phase 59 Metastatic Colorectal Cancer 59 Test Detects 59 Previously Treated 59 Sustained Efficacy 59 Randomized Comparison 59 Protein Linked 59 Cardiac Function 59 Ischemic Stroke 59 #-# Full Text 59 Randomized Phase II 59 Radiation Induced 59 Acute Myocardial Infarction 59 Novel Mechanism 59 Advanced Melanoma 59 Study Confirms 59 Antitumor Activity 59 Hormone Refractory Prostate Cancer 59 Multiple Myeloma Patients 59 Induces 59 Postmenopausal Women 59 Drug Candidate 59 Recurrent Breast Cancer 59 Study Proves 59 Severe Sepsis 59 Myocardial Infarction 59 Patients Treated With 59 Monotherapy 59 Childhood Asthma 59 Intravascular 59 Renal Cell Carcinoma 59 Randomized Double blind 59 Tumor Progression 59 Unfractionated Heparin 59 Acute Ischemic Stroke 59 Relapsed Refractory 59 Cell Transplants 59 Combination Treatment 59 Holds Promise 59 Tumor Growth 59 Protease Inhibitor 59 Phase III Clinical Trial 59 Immunosuppression 59 Ranolazine 59 Inhaled Corticosteroids 59 Preclinical Data 59 Stent Restenosis 59 Statin Therapy 59 II Clinical Trial 59 Phase IIa Clinical Trial 59 Cell Differentiation 59 Phase 2b Clinical Trial 59 Adjunctive Therapy 59 Observational Study 59 Demonstrates Significant 59 Cognitive Function 59 Improve Survival 59 Prevent Stroke 59 Reduces Risk 58 Randomized Double Blind Placebo 58 Insulin Resistance 58 Treatment Reduces 58 Gene Mutation 58 Cost Effectiveness 58 Glycemic Control 58 Clinical Efficacy 58 Septic Shock 58 Sirolimus Eluting Stent 58 Inflammatory Markers 58 Study Examines 58 Relapsed Multiple Myeloma 58 Genetic Markers 58 Refractory Hodgkin Lymphoma 58 Placebo Controlled Study 58 Inflammatory Arthritis 58 Demonstrates Efficacy 58 Unresectable 58 Completes Enrollment 58 Treated Patients 58 Pivotal Study 58 Kidney Function 58 Dose Ranging Study 58 Radiofrequency Ablation 58 Randomized 58 Multicenter 58 Survival Rates 58 Effective Treatments 58 Antiviral Therapy 58 Peripheral Blood 58 Antitumor 58 Skeletal Muscle 58 Fracture Risk 58 Invasive Fungal Infections 58 Randomized Controlled Trials 58 Long Term Survival 58 Subtypes 58 Bivalirudin 58 Balloon Angioplasty 58 Study Suggests 58 Chemotherapeutic Agents 58 Solid Tumors 58 Treating Chronic 58 Intravitreal 58 Osteoarthritis Patients 58 Hematological Cancers 58 Therapy Reduces 58 Partial Onset Seizures 57 Therapeutic Efficacy 57 Kidney Transplant Recipients 57 Renal Tumors 57 Chronic Renal Failure 57 Aggressive Drug Evaluation 57 Remission Maintenance 57 Insulin Glargine 57 Improved Survival 57 Dose Escalation 57 Study Showed 57 Cardiogenic Shock 57 Study Indicates 57 Rheumatoid Arthritis Patients 57 See CLINICAL PHARMACOLOGY 57 Immune Responses 57 Study Shows Benefits 57 Levels Linked 57 Confirms Efficacy 57 Genes Linked 57 ST Segment Elevation 57 Eluting 57 Carotid Revascularization Endarterectomy vs. 57 Blood Vessel 57 Invasive Breast Cancer 57 Meets Primary Endpoint 57 Preterm Infants 57 Researchers Identify 57 Investigational Compound 57 Novel Therapeutic 57 Lowers Risk 57 Genetic Variation 57 Investigational Drug 57 Shows Efficacy 57 Intervention Effectiveness 57 Demonstrates Statistically Significant 57 Attenuates 57 Controlled Clinical Trial 57 Laryngeal Cancer 57 Multicenter Trial 57 Clostridium difficile Infection 57 Complete Remission 57 Effectively Treats 57 Well Tolerated 57 Multicenter Randomized Double 57 Receives Orphan Drug Designation 57 Genetic Marker 57 Pivotal Trial 57 Novel Treatments 57 Lipid Lowering 57 HALTS 57 Renal Artery 57 Significantly Reduces 57 Help Predict 57 Potent Inhibitor 57 Nuclear Receptors 57 Minimally Invasive Treatment 57 Helps Identify 57 Node Negative 57 Cardiac Resynchronization 57 Diabetic Nephropathy 57 Bone Mineral Density 57 Completes Patient Enrollment 57 Genetic Diversity 57 Renal Function 57 unfractionated heparin UFH 57 Gastric Cancer 57 Randomized Placebo Controlled 57 Survival Benefit 57 Metabolic Efficiency 57 Lung Injury 57 Paclitaxel Eluting 57 Chronic Hepatitis B 57 Systolic Hypertension 57 Treatment Naive Patients 57 Therapy Shows Promise 57 Multicentre 57 Diabetic Patients 57 Novel Oral 57 Protein Involved 57 Beneficial Effects 57 Secondary Hyperparathyroidism 57 Therapeutic Potential 57 Parathyroid Hormone 57 Increased Risk 57 Preterm Delivery 57 Molecular Basis 57 Postmenopausal Hormone Therapy 57 Cocaine Addiction 57 Severe Asthma 57 Phase IIb Clinical Trial 56 Acute Coronary Syndromes 56 multicenter phase 56 Guidelines Issued 56 Double Blind Placebo 56 Prognostic Significance 56 NSABP B 56 Kidney Transplants 56 Combination Therapy 56 Demonstrates Positive 56 Castration Resistant Prostate Cancer 56 Helps Predict 56 Renal Insufficiency 56 Angiogenic 56 Lymph Nodes 56 Is Well Tolerated 56 Novel Approach 56 Glatiramer Acetate 56 Statistically Significant 56 Pivotal Phase 56 Unstable Angina 56 Presents Preclinical Data 56 FDA Approves Drug 56 Gene Variant 56 Reduced Risk 56 Complicated Skin 56 Previously Untreated 56 Genes Predict 56 GISSI 56 Scientists Identify 56 Data Suggest 56 Stem Cell Transplants 56 Antidepressant Treatment 56 Blood Flow 56 Inflammatory Response 56 Randomized Clinical Trials 56 Hepatocellular Carcinoma 56 Cyclophosphamide 56 Multicenter Randomized 56 Xelox 56 Kinase Inhibitor 56 Ischemic 56 Randomized Phase III 56 Efficacy Trial 56 Study Shows Significant 56 Neoadjuvant 56 Magnetic Nanoparticles 56 Study Casts Doubt 56 Adenoma Prevention 56 Epoetin Alfa 56 Cognitive Decline 56 Tiotropium 56 Mimetics 56 Tissue Engineered 56 Percutaneous Coronary Intervention 56 Investigational Agent 56 Clinical Antipsychotic Trials 56 Pivotal Trials 56 Risk Stratification 56 Lung Cancer Drug 56 Cancer Cells 56 Plus Ribavirin 56 Kidney Transplant Patients 56 Advanced Pancreatic Cancer 56 Enoxaparin 56 Tumor Cell 56 Renal Impairment 56 Hormonal Therapy 56 HER2 Positive Breast Cancer 56 Osteoporosis Treatment 56 Breast Carcinoma 56 Peginterferon 56 Chronic Heart Failure 56 Neural Stem Cells 56 Gene Mutations 56 Thyroid Hormone 56 JAK Inhibitor 56 Demonstrate Significant 56 Epithelial Cells 56 Safety Tolerability 56 Long Term Outcomes 56 Stem Cell Treatment 56 Nicotine Vaccine 56 Alternative Approaches 56 Initiates Clinical Trial 56 Molecular Mechanism 56 Renal Cancer 56 Muscle Function 56 Cancer Incidence Mortality 56 Sleep Disturbances 56 Early Diagnosis 56 Coronary Arteries 56 Overactive Bladder 56 Study Compares 56 Phase 2b Trial 56 Estrogen Receptor 56 Stable Angina 56 Skin Lesions 56 Genes Involved 56 Initiate Phase III 56 Bare Metal Stents 56 Breast Density 56 Therapy Improves 56 Low Dose 56 Orally Active 56 Slow Progression 56 Macrophage 56 Pregnancy Linked 56 Clopidogrel 56 Prevent Heart 56 Stent Implantation 55 Coronary Revascularization 55 Treat Anemia 55 Dose Response 55 multicenter multinational 55 Advanced Prostate Cancer 55 Asthma Treatment 55 Osteoporosis Drug 55 Novel Method 55 Randomised Trial 55 #:#-# [037] 55 Improve Outcomes 55 Breast Cancers 55 TB Vaccine 55 Pediatric Patients 55 Catheter Ablation 55 Antiretroviral Therapy 55 Prolongs Life 55 multicenter randomized controlled 55 Cognitive Deficits 55 Thrombotic 55 Fondaparinux 55 Patients Suffering 55 Homeostasis 55 Phase IIb Trial 55 Could Save Lives 55 Breast Cancer Metastasis 55 Drug Eluting 55 Dual Antiplatelet Therapy 55 Genes Identified 55 Randomized Placebo Controlled Trial 55 Endarterectomy 55 DEFER 55 Iron Deficiency 55 Epithelial 55 Prognostic Value 55 Significantly Improves 55 Cardiovascular Risk Factors 55 Desvenlafaxine Succinate 55 EURIDIS 55 Clinical Outcomes 55 Antibiotic Use 55 Replacement Therapy 55 Antiviral Activity 55 Systemic Delivery 55 Obesity Linked 55 CHMP Opinion 55 Fixed Dose 55 Beta Blockers 55 Demonstrates Potent 55 Shows Statistically Significant 55 Eluting Stent 55 Clinical Study 55 Therapeutic Antibody 55 Outpatient Setting 55 Suppresses 55 Modulates 55 Single Dose 55 Raloxifene Evaluation MORE 55 Tumor Targeted 55 Antipsychotic Drugs 55 Tumor Cells 55 5 Fluorouracil 55 Breast Tumors 55 Viral Load 55 Analytical Tool 55 Cardiopulmonary Bypass 55 Bevacizumab 55 Study Raises Questions 55 Lung Function 55 Androgen Deprivation Therapy 55 Metastatic Renal Cell Carcinoma 55 Oxygen Saturation 55 Inflammatory Pain 55 Demonstrates Sustained 55 Prostate Cancer Treatment 55 Disease Progression 55 Bone Marrow Cells 55 Endothelial Cells 55 Initiate Phase 55 Researchers Uncover 55 Contrast Agents 55 Blind Placebo Controlled 55 Pregnancy Outcomes 55 Phenotypes 55 Interferon Alfa 55 Poorly Controlled 55 Tumor Response 55 Insulin Sensitivity 55 Combo Therapy 55 Diet Linked 55 Drug Prevents 55 Gene Linked 55 Monoclonal Antibody 55 Potentially Fatal 55 Fungal Infections 55 Tolerability 55 Therapeutic Intervention 55 CLINICAL PHARMACOLOGY 55 Antiplatelet Therapy 55 Demonstrated Significant 54 Protein Expression 54 Intra Arterial 54 Strongly Linked 54 Presents Positive 54 Diabetic Neuropathy 54 Confirmatory Phase 54 Prophylactic Treatment 54 Study Shows 54 Pharmacodynamics 54 Intraocular Pressure 54 Non Responders 54 Postmenopausal 54 Treatment Naive 54 Potent Antiviral Activity 54 Blood Pressure Drugs 54 Stenting 54 Colorectal Cancer Patients 54 Combination REOLYSIN R 54 Achieves Primary Endpoint 54 Dry Powder Inhalers 54 Insulin Therapy 54 Angiotensin Converting Enzyme 54 Pressure Monitoring 54 Study Sheds Light 54 Brain Atrophy 54 Pluripotent Stem Cells 54 Relapsing Remitting Multiple Sclerosis 54 Treatment Regimen 54 Cervical Spine 54 Watchful Waiting 54 Gender Differences 54 Reperfusion 54 Slows Progression 54 Blood Pressure Drug 54 Myelodysplastic Syndrome MDS 54 Myocardial Infarction Study 54 phase IIIb 54 Zicam Extreme 54 Inhaled Nitric Oxide 54 Non Invasive 54 Successfully Completes Phase 54 Vitro Activity 54 STRIDE PD 54 Breast Cancer Treatment 54 Investigational Treatment 54 Related Mortality 54 Neuroprotective Effects 54 Phase III Pivotal Trial 54 Based Regimens 54 Multicenter Phase 54 Recombinant Human 54 Etanercept 54 Cholesterol Levels 54 Evaluation WISE 54 Pegylated Liposomal Doxorubicin 54 Brain Function 54 Blocked Arteries 54 Who Underwent 54 Phase III randomized 54 Functional Assessment 54 sunitinib Sutent 54 Could Detect 54 Guidelines Recommend 54 Efficacy Study 54 Cell Adhesion 54 Being Studied 54 Induction Chemotherapy 54 Phase 2a Trial 54 Corticosteroid 54 Cardiac Arrest Patients 54 Anti Tumor 54 Prognostic Factors 54 Oral Mucositis 54 Therapy Helps 54 Data Indicate 54 Malignant Glioma 54 Peripheral Arterial 54 Breast Cancer Stem Cells 54 Study Validates 54 Impairs 54 Genetic Predisposition 54 Cognitive Problems 54 Statin Drugs 54 Premature Infants 54 Leukemia Cells 54 Aliskiren 54 Provides Clues 54 Interferon Gamma 54 Nonalcoholic Fatty Liver Disease 54 Tumor Suppressor Gene 54 multicentre randomized 54 Endothelial 54 Zoledronic Acid 54 Patency 54 Vertebral Fractures 54 Study Assesses 54 Naive Patients 54 CORD II 54 Neurologic Disorders 54 Spectrum Pharmaceuticals Announces 54 Functional Outcomes 54 Protein Synthesis 54 Enzastaurin 54 Menopausal Symptoms 54 Initiates Phase II 54 Occlusion 54 Synaptic Plasticity 54 Bone Metabolism 54 Racial Differences 54 Experimental Vaccine 54 Aggressive Prostate Cancer 54 Docosahexaenoic Acid 54 Help Detect 54 Brain Metastases 54 Hospitalized Patients 54 Lung Cancer Survival 54 Present Preclinical Data 54 Significantly Improved 54 Prophylaxis 54 Nerve Cells 54 Therapeutic Approaches 54 Ventricular 54 Restenosis 53 Pharmacokinetics PK 53 Myocardial 53 Fewer Side Effects 53 Versus Placebo 53 Drug Eluting Stents 53 Protease Inhibitors 53 Study Analyzes 53 Device Helps 53 Metastatic Melanoma 53 Correlation Between 53 Novel Peptide 53 Efficacy 53 Depressive Symptoms 53 Tumor Suppressor 53 Teduglutide 53 Regimens 53 Bone Fractures 53 Etiology 53 Immune Cells 53 FDA Approvals 53 First Patient Dosed 53 Risedronate 53 Premenopausal Women 53 Treatment Outcome 53 Stent Thrombosis 53 Menstrual Pain 53 Brain Stimulation 53 Malaria Vaccine 53 Breast Tissue 53 Denufosol 53 ritonavir boosted 53 Smoking Linked 53 Psoriasis Drug 53 Immune Cell 53 Phase 2a Clinical Trial 53 Infected Patients 53 Nebulized 53 NCT# ClinicalTrials.gov 53 Commonly Used 53 Receptor Signaling 53 Estrogen Therapy 53 Blood Vessels 53 Anti Angiogenic 53 Tumor Targeting 53 Comorbidities 53 Significantly Reduced 53 Sleep Duration 53 Breast Cancer Risk 53 Vertebral Fracture 53 J Nutr 53 Nicotine Addiction 53 Azacitidine 53 Mortality Risk 53 Initiated Phase 53 Clogged Arteries 53 Anticancer Activity 53 Benign Prostatic Hyperplasia 53 BZA CE 53 Mesothelioma Treatment 53 Dendritic Cells 53 Intracranial Aneurysms 53 Evoked 53 Pivotal Phase III 53 Genotypes 53 Breast Tumor 53 Blood Pressure Monitoring 53 Blood Pressure Lowering 53 Diabetic Foot Ulcer 53 Antithrombin 53 dual endothelin receptor antagonist 53 randomized multicenter 53 HDAC Inhibitor 53 ExTRACT TIMI 53 Cholesterol Drugs 53 Begin Clinical Trials 53 Colorectal Adenomas 53 Begins Dosing 53 Prednisone Against Refractory 53 Anti Angiogenesis 53 Ischaemic 53 Diagnostic Criteria 53 Brain Cells 53 Prostate Cancer Risk 53 Adjuvant 53 Polymerase Inhibitor 53 Brain Scans 53 Co Principal Investigator 53 Small Molecule 53 Sandostatin R 53 Skin Cells 53 Vitamin D Levels 53 MGd 53 Vaccine Shows Promise 53 Uric Acid 53 Left Atrial 53 Anti Clotting Drug 53 Epilepsy Drug 53 TAXUS ATLAS 53 fosbretabulin 53 Eculizumab 53 randomized multicenter trial 53 Attack Trial ALLHAT 53 Thrombolysis 53 Percutaneous Tibial Nerve Stimulation 53 Lymph Node 53 Antihypertensive 53 Lung Cancer Trial 53 Urgently Needed 53 Hematopoietic 53 Symptom Improvement 53 Prevent Breast Cancer 53 Treatment Resistant 53 Asthma Symptoms 53 Exacerbation 53 Prenatal Exposure 53 Elevated Levels 53 Study Evaluates 53 Study Explores 53 Transcriptional 53 Panel Advises 53 Neuroprotection 53 Grants Awarded 53 R lenalidomide 53 Detection Device 53 Combination Clinical Trial 53 Peginterferon Alfa 2a 52 Degarelix 52 Glucose Metabolism 52 Anticoagulant 52 Adjunctive 52 Proves Successful 52 Hormone Therapy 52 Immune Function 52 Electrical Stimulation 52 Hepatitis C Genotype 52 Primary Endpoint 52 GOUT 52 Urine Test 52 Genetic Defect 52 Iron Overload 52 Lipid Levels 52 Ambulatory Blood Pressure 52 Pancreas Cancer 52 Kidney Donors 52 Embryonic Stem Cells 52 Aortic Dissection 52 Antiviral Drugs 52 Induced Pluripotent Stem Cells 52 Mental Decline 52 Decitabine 52 Drug Resistant 52 Can Predict 52 Hedgehog Pathway 52 Demonstrates Ability 52 Could Prevent 52 Bosutinib 52 Adipose Tissue 52 3 Fatty Acids 52 Differential Diagnosis 52 Angiographic 52 Gene Variation 52 Effort Needed 52 TO AVOID PREGNANCY WHILE 52 number NCT# ClinicalTrials.gov 52 Lung Tumors 52 Systematic Approach 52 Mucosal 52 Melphalan 52 Hepatic Encephalopathy 52 Reduces Pain 52 Edge STudy 52 TMC# C# 52 Myoblast 52 Initiates Phase 52 Anticoagulation 52 Calcium Intake 52 Epidermal Growth Factor Receptor 52 prospective observational 52 Therapeutic Effects 52 Predict Prostate Cancer 52 Humanized Anti 52 Thoracic Aortic Aneurysms 52 Endovascular Treatment 52 Trial Halted 52 Predict Dementia 52 Brain Shrinkage 52 Secondhand Smoke Exposure 52 Antidepressants Linked 52 Orthostatic Hypotension 52 Antipsychotic Drug 52 Novel Inhibitor 52 Initiate Clinical Trial 52 Non Inferiority 52 HCV Protease Inhibitor 52 Pharmacodynamic 52 Proteasome 52 Atypical Antipsychotic 52 RE MODEL 52 BiTE Antibody 52 Autoimmune Disease 52 Nilotinib 52 Cardiotoxicity 52 Eradicates 52 Better Outcomes 52 Hip Fracture 52 colesevelam HCl 52 Genetic Variants 52 Hepatitis C Treatment 52 Prostate Cancer Cells 52 Screening Mammography 52 Study Concludes 52 Receptor Antagonist 52 Lupus Drug 52 Survival Rate 52 Clinical Practice Guidelines 52 Treatment Naive HIV 52 Exposure Linked 52 Trial NLST 52 Inhibit 52 Could Revolutionize 52 Nebulized Formoterol 52 Could Harm 52 Naturally Occurring 52 Multiple Ascending Dose 52 Play Crucial Role 52 Be Studied 52 Vaccine Prevents 52 Virus Infection 52 APTIVUS 52 interferon gamma 1b 52 Adverse Outcomes 52 Inhaled Liposomal Ciprofloxacin 52 Quadrivalent 52 Negative Effects 52 Morbidity Mortality 52 Cyclooxygenase 2 52 Drug Regimen 52 Molecular Mechanisms 52 Underlies 52 Single Molecule 52 Blind Placebo Controlled Trial 52 Reduce Mortality 52 Researchers Develop 52 Viral Suppression 52 Heart Failure Therapy 52 Late Breaker 52 Patient Outcomes 52 Nuclear Receptor 52 Improve Diagnosis 52 Imaging Technique 52 Expert Discusses 52 selective phosphodiesterase 52 Transcription Factor 52 Treat Heart Failure 52 Pharmacokinetics 52 prospective multicentre 51 Blood Transfusions 51 Abnormality 51 Polyneuropathy 51 Glucocorticoid 51 Gout Drug 51 multicentre randomized double 51 Smooth Muscle 51 Drug Coated Stents 51 Ebola Vaccine 51 multicentre 51 Therapeutic Antibodies 51 Metastatic Cancer 51 Nerve Cell 51 Platelet Aggregation 51 Clinical Trial Data 51 Intervention Effectiveness CATIE 51 multicenter randomized double 51 Clin Trials 51 Malformations 51 Pathogen Detection 51 Thromboembolic 51 Phase III Trials 51 Treatment Approaches 51 Capecitabine 51 Adalimumab 51 #:#-#,# [003] 51 Viral Infections 51 Lymphocyte 51 daily Infergen 51 Gene Mutation Linked 51 Pancreatic Islet 51 Novel Compound 51 Lipid Lowering Treatment 51 Epithelial Cell 51 Rosuvastatin 51 Scientists Warn 51 EVEREST II 51 Hypercholesterolemia 51 IND Application 51 Zinc Finger Nucleases 51 Treating Depression 51 Pralatrexate 51 HYVET 51 candesartan cilexetil 51 Tumor Markers 51 Prostate Cancer Diagnosis 51 Bile Acid 51 Fludarabine 51 Anti Inflammatory Drugs 51 C Reactive Protein 51 Virologic 51 Bowel Disease 51 Nerve Regeneration 51 Juvenile Idiopathic Arthritis 51 Prospective Cohort Study 51 Tocilizumab 51 Molecular Pathogenesis 51 LUX Lung 51 Ocrelizumab 51 Gene Variants 51 Blood Clotting 51 Plays Role 51 SABCS 51 Fulvestrant 51 Fibrinogen 51 Efficacious 51 Interferon Beta 51 Genetic Tests 51 Lesion 51 #:#-#,# CrossRef Medline [002] 51 Acute Exacerbations 51 Stress Induced 51 Digestive Tract 51 Improve Quality 51 pegylated liposomal doxorubicin 51 Fasting Glucose 51 Adverse Event 51 Community Acquired Pneumonia 51 Progenitor Cell 51 Study Reinforces 51 Drug Resistant Tuberculosis 51 Treat Parkinson Disease 51 Randomized phase 51 Study Identifies 51 Multiethnic Study 51 Radiation Exposure 51 Romiplostim 51 Radiofrequency Ablation RFA 51 Lenalidomide 51 Phase III multicenter 51 Lowers Blood Pressure 51 Relapsed 51 Patent Covering 51 Oral Anticoagulant 51 Receptor Agonist 51 Phase Ib II 51 PKC# 51 Mycophenolate Mofetil 51 Study Recommends 51 Transgenic Mice 51 Yields Clues 51 Tanespimycin 51 Bone Marrow Stem Cells 51 Proton Pump Inhibitors 51 Cardiovascular Risk Reduction 51 Cervical Dysplasia 51 Secretory 51 Tipranavir 51 Substantially Reduce 51 Significant Efficacy 51 Immunogenicity 51 Helps Relieve 51 Testosterone Levels 51 plus prednisone 51 Male Infertility 51 Temsirolimus